Freeline to Present New Clinical Data for FLT180a in Hemophilia B at International Society on Thrombosis and Haemostasis Congress

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline files registration statement for proposed initial public offering in the United States
Freeline Appoints Colin Love, PhD to Board of Directors
Freeline Doses Second Patient of Phase 1/2 MARVEL-1 Clinical Trial for Fabry Disease
Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference
Freeline Reports Full Year 2022 Financial Results and Provides Corporate Update
Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels